Abstract
Breast cancer is the most common cancer in American women with approximately 230,000 cases diagnosed annually [1]. Women in the United States have a 1 in 8 chance of developing the disease. While most cases of breast cancer do not have a strong familial component, it is estimated that approximately 5–10 % of cases of breast cancer are due to a known genetic factor [2]. In women with a known BRCA 1 or 2 mutation, 40–66 % will eventually develop breast cancer (compared to 10–12 % in the general population) [3]. In response, The American College of Medical Genetics published guidelines for genetic testing for breast and ovarian cancer in 1999.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
ACS Cancer Facts and Figures. Available at: http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2011 (2011). Accessed 2 Dec 2011.
Genetic susceptibility to breast and ovarian cancer: assessment, counseling and testing guidelines. American College of Medical Genetics; 1999.
Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329–33.
Schlich-Bakker KJ, ten Kroode HFJ, Ausems MGEM. A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns. 2008;62:13–20.
Power TE, Robinson JW, Bridge P, Bernier FP, Gilchrist DM. Distress and psychosocial needs of a heterogeneous high risk familial cancer population. J Genet Couns. 2011;20:249–69.
Dagan E, Shochat T. Quality of life in asymptomatic BRCA1/2 mutation carriers. Prev Med. 2009;48:193–6.
Watson M, Lloyd SM, Eeles R, et al. Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: an investigation of two families in the research setting. Psychooncology. 1996;5:233–9.
Vadaparampil ST, Miree CA, Wilson C, Jacobsen PB. Psychosocial and behavioral impact of genetic counseling and testing. Breast Dis. 2006;27:98–108.
Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology. 2005;14:1060–74.
Armes JE, Venter DJ. The pathology of inherited breast cancer. Pathology. 2002;34:309–14.
Vink GR, van Asperen CJ, Devilee P, Breuning MH, Bakker E. Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counseling, a proposal for guidelines. Eur J Hum Genet. 2004;13:525–7.
Di Propspero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, et al. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. Can Med Assoc J. 2001;164:1005–9.
Beran TM, Stanton AL, Kwan L, Seldon J, Bower JE, Vodermaier A, Ganz PA. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Ann Behav Med. 2008;36:107–16.
van Oostrom I, Meijers-Heijboer H, Lodder LN. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow up study. J Clin Oncol. 2003;21:3867–74.
den Heijer M, Vos J, Seynaeve C, Vanheusden K, Duivenvoorden HJ, Tilanus-Linthorst M, Menke-Pluymers MBE, Tibben A. The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer. Psycho-Oncology. 2010; doi:10.1879.
den Heijer M, Seynaeve C, Vanheusden K, Duivenvoorden HJ, Bartels CCM, Menke-Pluymers MBE, Tibben A. Psychological distress in women at risk for hereditary breast cancer: the role of family communication and perceived social support. Psycho-Oncology. 2010; doi:10.1850.
Ertmanski S, Metcalfe K, Trempala J, Glowacka MD, Lubinski J, Narod SA, Gronwald J. Identification of patients at high risk of psychological distress after BRCA1 genetic testing. Genet Test Mol Biomarkers. 2009;13(3):325–30.
Dougall AL, Smith AW, Somers TJ, Posluszny DM, Rubinstein WS, Baum A. Coping with genetic testing for breast cancer susceptibility. Psychosom Med. 2009;71:98–105.
Annunziata MA, Muzzatti B, Narciso D, Mella S, Viel A, Bidoli E, Dolcetti R. Mood state profile and coping strategies after BRCA-1/2 genetic test disclosure: a retrospective study in Italy. Support Care Cancer. 2011;19:733–5.
Landsbergen KM, Brunner HG, Manders P, Hoogerbrugge N, Prins JB. Educational support groups for BRCA mutation carriers satisfy need for information but do not affect emotional distress. Genet Couns. 2010;21(4):423–37.
Roussi P, Sherman KA, Miller S, Buzagio J, Daly M, Taylor A, Ross E, Godwin A. Enhanced counseling for women undergoing BRCA ½ testing: impact on knowledge and psychological distress-results from a randomised clinical trial. Psychol Health. 2010;25(4):401–15.
Hooker GW, Leventhal KG, DeMarco T, Peshkin BN, Finch C, Wahl E, Joines JR, Brown K, Valdimarsdottir H, Schwartz MD. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized clinical trial. Med Decis Making. 2011;31(3):412–21.
Phelps C, Bennett P, Jones H, Hood K, Brain K, Murray A. The development of a cancer genetic-specific measure of coping: the GRACE. Psychooncology. 2010;19(8):847–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pearman, T. (2013). Psychological Implications of Testing Positive for the BRCA Gene. In: Hansen, N. (eds) Management of the Patient at High Risk for Breast Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5891-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5891-3_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5890-6
Online ISBN: 978-1-4614-5891-3
eBook Packages: MedicineMedicine (R0)